# Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/simvastatin-inhibits-osteoclast-differentiation-induced-by-bone-morphogenetic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Misuzu Yamashita,Fumio Otsuka,Tomoyuki Mukai,Ryutaro Yamanaka,Hiroyuki Otani,Yoshinori Matsumoto,Eri Nakamura,Mariko Takano,Ken‐ei Sada,Hirofumi Makino |
| Citations | 89 |
| DOI | 10.1016/j.regpep.2010.03.003 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2015019709 |
| PMID | 20346376 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Yoshinori Matsumoto](https://scholariq.org/researchers/yoshinori-matsumoto/)
- [Ken‐ei Sada](https://scholariq.org/researchers/ken-ei-sada/)

## Paper primary topic

- [Bone Metabolism and Diseases](https://scholariq.org/topics/bone-metabolism-and-diseases/)

## Paper topics

- [Bone Metabolism and Diseases](https://scholariq.org/topics/bone-metabolism-and-diseases/)
- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)
- [NF-κB Signaling Pathways](https://scholariq.org/topics/nf-b-signaling-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.